Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion ... This tragic saga began in 1996, when OxyContin was released in a 10 milligram tablet ...

Under the new proposal, like the previous one, members of the Sackler family would ... it protected members of the wealthy family from civil lawsuits over OxyContin — even though the family ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.